Optimize your syngeneic models with genetically engineered cell lines
Channel: genOway SA
Date: 2020-01-08

While syngeneic models represent a very powerful tool to assess tumor immune response in immunotherapy, there are a few concerns about the translational value derived from studies using such models.
In this webinar, Dr. Amélie Rezza explains how well-designed and thoroughly characterized genetically modified tumor cell lines can optimize syngeneic models by maximizing their clinical relevance. www.genoway.com